Logo image of PHO.OL

PHOTOCURE ASA (PHO.OL) Stock Price, Quote, News and Overview

OSL:PHO - Euronext Oslo - NO0010000045 - Common Stock - Currency: NOK

50.2  +0.5 (+1.01%)

PHO.OL Quote, Performance and Key Statistics

PHOTOCURE ASA

OSL:PHO (5/30/2025, 7:00:00 PM)

50.2

+0.5 (+1.01%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High69
52 Week Low47
Market Cap1.36B
Shares27.12M
Float26.18M
Yearly DividendN/A
Dividend YieldN/A
PE2510
Fwd PE24.7
Earnings (Next)07-30 2025-07-30
IPO05-29 2000-05-29


PHO.OL short term performance overview.The bars show the price performance of PHO.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4

PHO.OL long term performance overview.The bars show the price performance of PHO.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of PHO.OL is 50.2 NOK. In the past month the price decreased by -5.78%. In the past year, price decreased by -23.02%.

PHOTOCURE ASA / PHO Daily stock chart

PHO.OL Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 53.21 615.27B
1LLY.MI ELI LILLY & CO 53.16 614.70B
ZEG.DE ASTRAZENECA PLC 16.47 395.77B
1JNJ.MI JOHNSON & JOHNSON 15.29 327.71B
JNJ.DE JOHNSON & JOHNSON 15.27 327.47B
NOV.DE NOVO NORDISK A/S-B 19.78 276.91B
RHO.DE ROCHE HOLDING AG-BR 14.88 242.45B
1SAN.MI SANOFI 12.22 228.72B
SAN.PA SANOFI 11.38 213.00B
SNW.DE SANOFI 11.38 212.90B
NOT.DE NOVARTIS AG-REG 13.7 198.89B
1MRKX.MI MERCK & CO. INC. 9.9 171.75B

About PHO.OL

Company Profile

PHO logo image Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. The company is headquartered in Oslo, Oslo and currently employs 101 full-time employees. The company went IPO on 2000-05-29. The firm is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.

Company Info

PHOTOCURE ASA

Hoffsveien 4

Oslo OSLO NO

Employees: 100

PHO Company Website

PHO Investor Relations

Phone: 4722062210

PHOTOCURE ASA / PHO.OL FAQ

What is the stock price of PHOTOCURE ASA today?

The current stock price of PHO.OL is 50.2 NOK. The price increased by 1.01% in the last trading session.


What is the ticker symbol for PHOTOCURE ASA stock?

The exchange symbol of PHOTOCURE ASA is PHO and it is listed on the Euronext Oslo exchange.


On which exchange is PHO.OL stock listed?

PHO.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for PHOTOCURE ASA stock?

8 analysts have analysed PHO.OL and the average price target is 82.88 NOK. This implies a price increase of 65.09% is expected in the next year compared to the current price of 50.2. Check the PHOTOCURE ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PHOTOCURE ASA worth?

PHOTOCURE ASA (PHO.OL) has a market capitalization of 1.36B NOK. This makes PHO.OL a Small Cap stock.


How many employees does PHOTOCURE ASA have?

PHOTOCURE ASA (PHO.OL) currently has 100 employees.


What are the support and resistance levels for PHOTOCURE ASA (PHO.OL) stock?

PHOTOCURE ASA (PHO.OL) has a support level at 49.35 and a resistance level at 50.31. Check the full technical report for a detailed analysis of PHO.OL support and resistance levels.


Is PHOTOCURE ASA (PHO.OL) expected to grow?

The Revenue of PHOTOCURE ASA (PHO.OL) is expected to grow by 11.38% in the next year. Check the estimates tab for more information on the PHO.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PHOTOCURE ASA (PHO.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PHOTOCURE ASA (PHO.OL) stock pay dividends?

PHO.OL does not pay a dividend.


When does PHOTOCURE ASA (PHO.OL) report earnings?

PHOTOCURE ASA (PHO.OL) will report earnings on 2025-07-30.


What is the Price/Earnings (PE) ratio of PHOTOCURE ASA (PHO.OL)?

The PE ratio for PHOTOCURE ASA (PHO.OL) is 2510. This is based on the reported non-GAAP earnings per share of 0.02 and the current share price of 50.2 NOK. Check the full fundamental report for a full analysis of the valuation metrics for PHO.OL.


PHO.OL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PHO.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to PHO.OL. No worries on liquidiy or solvency for PHO.OL as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PHO.OL Financial Highlights

Over the last trailing twelve months PHO.OL reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS decreased by -86.67% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.4%
ROA 0.3%
ROE 0.45%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%68.97%
Sales Q2Q%6.19%
EPS 1Y (TTM)-86.67%
Revenue 1Y (TTM)3.95%

PHO.OL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to PHO.OL. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 896.78% and a revenue growth 11.38% for PHO.OL


Ownership
Inst Owners50.48%
Ins Owners1.94%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.5
Price Target82.88 (65.1%)
EPS Next Y896.78%
Revenue Next Year11.38%